hydralazine has been researched along with uric acid in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (90.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Child, A; Duggin, GG; Hall, BM; Henderson-Smart, D; Horvath, JS; Korda, A; Phippard, A; Tiller, DJ | 1 |
| Jahnecke, J | 1 |
| Clark, GM; Troop, RC | 1 |
| Jacobs, RP | 1 |
| Barsotti, G; Cristofano, C; Giovannetti, S; Mezzomo, N | 1 |
| Perry, HM | 1 |
| Broughton Pipkin, F; Lamming, GD; Symonds, EM | 1 |
| Shapiro, AP; Traub, YM | 1 |
| Chang, TT; Chen, C; Chen, JW; Chiang, CH; Lee, HJ; Lin, SC | 1 |
3 trial(s) available for hydralazine and uric acid
| Article | Year |
|---|---|
Effects of treatment on morbidity in hypertension. 3. Influence of age, diastolic pressure, and prior cardiovascular disease; further analysis of side effects.
Topics: Adult; Age Factors; Aged; Aneurysm; Atrial Fibrillation; Blood Glucose; Blood Pressure; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Disease; Glomerulonephritis; Heart Failure; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Hypokalemia; Male; Middle Aged; Morbidity; Reserpine; Sampling Studies; Uric Acid | 1972 |
One-tablet combination drug therapy in the treatment of hypertension.
Topics: Blood Glucose; Blood Pressure; Blood Urea Nitrogen; Clinical Trials as Topic; Dosage Forms; Drug Combinations; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Potassium; Pulse; Reserpine; Tablets; Uric Acid | 1972 |
Comparison of the alpha and beta blocking drug, labetalol, and methyl dopa in the treatment of moderate and severe pregnancy-induced hypertension.
Topics: Adult; Blood Pressure; Creatinine; Ethanolamines; Female; Fetus; Humans; Hydralazine; Hypertension; Labetalol; Labor, Obstetric; Metabolic Clearance Rate; Methyldopa; Potassium; Pregnancy; Pregnancy Complications, Cardiovascular; Sodium; Uric Acid | 1980 |
7 other study(ies) available for hydralazine and uric acid
| Article | Year |
|---|---|
Hypertension in pregnancy. A study of 142 women presenting before 32 weeks' gestation.
Topics: Antihypertensive Agents; Clonidine; Diazoxide; Female; Humans; Hydralazine; Hypertension; Infant Mortality; Infant, Newborn; Methyldopa; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Trimester, Second; Uric Acid | 1985 |
[Side effects of antihypertensive agents].
Topics: Antihypertensive Agents; Arrhythmias, Cardiac; Diarrhea; Diuretics; Fatigue; Ganglionic Blockers; Gastric Mucosa; Humans; Hydralazine; Hypokalemia; Hyponatremia; Imidazoles; Methyldopa; Plants, Medicinal; Psychoses, Substance-Induced; Rauwolfia; Uric Acid | 1970 |
Drug-induced rheumatic diseases.
Topics: Adrenal Cortex Hormones; Anticonvulsants; Antineoplastic Agents; Diuretics; Gout; Heparin; Humans; Hydralazine; Lupus Erythematosus, Systemic; Myositis; Osteomalacia; Osteonecrosis; Osteoporosis; Procainamide; Rheumatic Diseases; Scleroderma, Systemic; Thyroid Hormones; Uric Acid | 1984 |
Serum uric acid in mild essential hypertension.
Topics: Adult; Aged; Combined Modality Therapy; Diet, Sodium-Restricted; Diuretics; Female; Humans; Hydralazine; Hypertension; Male; Middle Aged; Uric Acid | 1983 |
Some wrong-way chemical changes during antihypertensive treatment: comparison of indapamide and related agents.
Topics: Adult; Antihypertensive Agents; Chemical Phenomena; Chemistry; Chlorthalidone; Diuretics; Humans; Hydralazine; Hydrochlorothiazide; Hypercholesterolemia; Hyperglycemia; Hypokalemia; Indapamide; Middle Aged; Myocardial Infarction; Uric Acid | 1983 |
Complications of antihypertensive therapy.
Topics: Antihypertensive Agents; Benzothiadiazines; Clonidine; Diuretics; Female; Guanethidine; Humans; Hydralazine; Hyperglycemia; Hypertension; Hypokalemia; Male; Methyldopa; Minoxidil; Prazosin; Propranolol; Reserpine; Sodium Chloride Symporter Inhibitors; Uric Acid | 1981 |
Antioxidation and Nrf2-mediated heme oxygenase-1 activation contribute to renal protective effects of hydralazine in diabetic nephropathy.
Topics: Allopurinol; Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glucose; Heme Oxygenase-1; Hydralazine; Kidney; Mice; NADPH Oxidases; NF-E2-Related Factor 2; Oxidative Stress; Reactive Oxygen Species; Uric Acid | 2022 |